Experts at SICP 2025 outline how molecular mechanisms and bedside assessments can guide personalised treatment for ...

Public Citizen is pressing the U.S. Food and Drug Administration (FDA) to strengthen the pregnancy warnings on widely used serotonin reuptake inhibitor (SRI) antidepressants, arguing that current drug ...

Research on adults who take S.S.R.I.s shows they tamp down sexual desire. Why aren’t we studying what that could mean for adolescents who take them? Credit...Photo illustration by The New York Times ...

Researchers found that patients with PTSD may benefit from a combination of pharmacotherapy and new therapies.

A new international Delphi study has shed light on the complexities surrounding Persistent Idiopathic Facial Pain (PIFP), a ...

Millions of Brits are told to avoid one specific fruit for important health reasons. Recent figures from the NHS Business Services Authority (NHSBSA) reveal that 8.7 million people across the UK are ...

This commentary on persistent idiopathic facial pain urges balanced dental and neurologic assessment, clearer differential ...

SNS Insider Highlights U.S. Neuropathic Pain Market Growth, Projected to Reach USD 5.47 Billion by 2033, Supported by Advanced Healthcare Systems, Innovative Pain Management Solutions, and Strong ...

Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid-2026More than 21 ...

Did you know that oestrogen has been used to treat menopausal symptoms since 1928? Now, there’s a new non-hormonal alternative and even the off-label use of medicines for hypertension, depression, ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...